Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by MHemorrhageon Feb 25, 2021 3:51pm
85 Views
Post# 32660765

RE:RE:Posting this to Reddit - Thoughts?

RE:RE:Posting this to Reddit - Thoughts?
Wino115 wrote: Well done.  A couple items.

- didn't know ovarian and pancreatic markets were that small?
I stole these figures from scarlet's research, lemme poke around on Google to confirm

- In the financials, you list everything as current assets and liabilities.  Are those actually all current, or do you mean total assets and total liabilities? 
Thanks, have added the word "total" for the paranthetical number

- Given a 13D was filed, it is now kosher to soft-pedal the fact that Soleus, a circa $700bil healthcare investor who was an early investor in  Immunomedics (taken out at $21bil by Gilead), BioAtla and many other cancer-oriented biotechs, is now one of the larger shareholders.  I wouldn't go much beyond the factual reporting we know from the 13D they filed. 

Niiiiice, def adding this in

<< Previous
Bullboard Posts
Next >>